Nkarta, Inc. (NKTX)
3.25
-0.05
(-1.52%)
USD |
NASDAQ |
May 29, 16:00
3.24
-0.01
(-0.31%)
After-Hours: 20:00
Nkarta Total Assets (Quarterly) : 372.07M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 1.148B |
| Gilead Sciences, Inc. | 56.28B |
| Inovio Pharmaceuticals, Inc. | 49.78M |
| ADMA Biologics, Inc. | 665.18M |
| Zenas BioPharma, Inc. | 747.68M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 86.21M |
| Shareholders Equity (Quarterly) | 285.86M |
| Debt to Equity Ratio | 0.2624 |
| Current Ratio | 12.96 |
| Net Debt Paydown Yield | 0.70% |